A new state-of-the-art cancer clinical diagnostics facility is to be installed at the Royal Marsden NHS Trust. The liquid biopsy testing facility will be a hub for related research and has been agreed upon following a partnership with Guardant Health, a leading precision oncology company. Guardant Health’s role will facilitate a rapid development of the unit’s technology, so that cancers…
Ben KempNovember 4, 2021

